High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs.

Source:http://linkedlifedata.com/resource/pubmed/id/16450374

Int. J. Cancer 2006 Jul 1 119 1 213-20

Download in:

View as

General Info

PMID
16450374